Federated Hermes
PRTK

Federated Hermes’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Federated Hermes’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-319
Closed -$2K – 2365
2021
Q1 		$2K Buy
319
+153
+92% +$1.1K ﹤0.01% 2141
2020
Q4 		$1K Buy
166
+16
+11% +$94 ﹤0.01% 2206
2020
Q3 		$1K Buy
+150
New +$743 ﹤0.01% 2213
2017
Q4 		– Sell
-35,428
Closed -$889K – 2244
2017
Q3 		$889K Buy
+35,428
New +$825K ﹤0.01% 1229
2017
Q2 		– Sell
-806
Closed -$16K – 2201
2017
Q1 		$16K Buy
+806
New +$12.7K ﹤0.01% 1765
2015
Q2 		– Sell
-338
Closed -$11K – 2099
2015
Q1 		$11K Buy
+338
New +$9.71K ﹤0.01% 1775

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's PRTK Position: Q2 2021 in Review

Federated Hermes sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2021, closing a stake of 319 shares — an estimated $2K sold.

Federated Hermes first reported a position in PRTK in Q1 2015 and held it in 6 quarters. The position peaked at $889K in Q3 2017. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.

  • Federated Hermes reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Federated Hermes sold 319 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $2K.
  • Federated Hermes first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2015 and held it in 6 quarters.
  • Federated Hermes's Paratek Pharmaceuticals, Inc. position peaked at $889K in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.

Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.